SIRT1 and acute kidney injury: NAM treatment significantly increased circulating NAD+ level and prevented perioperative AKI compared with placebo, suggesting that increasing NAD+ level is protective against PTC loss and kidney injury by enhancing Sirtuin-1 activity.